2017
DOI: 10.1186/s13012-017-0620-x
|View full text |Cite
|
Sign up to set email alerts
|

Barriers and facilitators to reducing frequent laboratory testing for patients who are stable on warfarin: a mixed methods study of de-implementation in five anticoagulation clinics

Abstract: BackgroundPatients on chronic warfarin therapy require regular laboratory monitoring to safely manage warfarin. Recent studies have challenged the need for routine monthly blood draws in the most stable warfarin-treated patients, suggesting the safety of less frequent laboratory testing (up to every 12 weeks). De-implementation efforts aim to reduce the use of low-value clinical practices. To explore barriers and facilitators of a de-implementation effort to reduce the use of frequent laboratory tests for pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
21
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(24 citation statements)
references
References 18 publications
1
21
0
1
Order By: Relevance
“…Determinant frameworks, specifically, are used to identify barriers and enablers of implementation [40]. To date, a number of empirical studies used the TICD and other theoretical frameworks to explore implementation issues across therapeutic areas, including lower back pain [41,42], hand hygiene [43], blood transfusion [44], medication prescribing [45], laboratory testing [46], polypharmacy [47], evidence-based recommendations for chronic conditions [48] and primary care [49], schizophrenia [50] and dementia [51]. In general, uncertainty about how to choose interventions that best match implementation determinants in a given context have been reported [52].…”
Section: Discussionmentioning
confidence: 99%
“…Determinant frameworks, specifically, are used to identify barriers and enablers of implementation [40]. To date, a number of empirical studies used the TICD and other theoretical frameworks to explore implementation issues across therapeutic areas, including lower back pain [41,42], hand hygiene [43], blood transfusion [44], medication prescribing [45], laboratory testing [46], polypharmacy [47], evidence-based recommendations for chronic conditions [48] and primary care [49], schizophrenia [50] and dementia [51]. In general, uncertainty about how to choose interventions that best match implementation determinants in a given context have been reported [52].…”
Section: Discussionmentioning
confidence: 99%
“…The steps include creating conditions for change, engaging in sense‐making conversations with care teams and allowing them to take a sense of ownership of the issue to make their own decision about where the balance of benefit and harm lies. Finally, several studies have adapted the Theoretical Domains Framework to guide or interpret de‐implementation findings . The Theoretical Domains Framework synthesizes psychological theories of behaviour change to help develop theoretically grounded behaviour‐change interventions.…”
Section: Discussionmentioning
confidence: 99%
“…However, these recommendations have changed, and though NZ best practice guidelines at present recommend testing no less often than every 6–8 weeks, evidence is accumulating that testing selected patients as infrequently as every 12 weeks is safe and feasible . Outside of clinical trials, however, extended intervals have yet not been widely adopted . Consequently, we have concerns that patients in our region are having inappropriate blood tests, with antecedent risks and misallocation of resources.…”
Section: Discussionmentioning
confidence: 99%
“…Possible methods for improving the appropriate interval of monitoring include provider education, and the use of electronic aids to identify patients where monitoring periods can be lengthened. The expenditure associated with these interventions may be balanced by savings in tests and clinician time; in our cohort, for example, shifting the group of patients with 100% TTR to monitoring every 12 weeks, rather than every 4 weeks, at a cost of NZ$12.2 per INR, would save NZ$107 000 per year, in direct test costs alone.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation